Download
Ceragem recliners earn recognition in medical journal for neuroergonomics
By Ko
Dong-hwan, The Korea Times - Ceragem, a health care company known for
popularizing massage beds and chairs, has demonstrated its technological
competence by earning recognition in the medical journal Frontiers for its work
in neuroergonomics.
Ceragem
said Thursday that the journal recommended the company’s recent study involving
its signature medical equipment lineup, the Master V Collection, confirming its
therapeutic effects in helping users recover from back-related issues.
Spearheaded
by researchers at NYU Langone Health, the study was jointly conducted by the
NYU Grossman School of Medicine, the City College of New York and Ceragem
Clinical, the company’s clinical research division. The study looked to verify
the purported benefits of the recliners, which feature heating and customized
massaging functions, through randomized controlled clinical trials.
The
results showed that the group using the Master V Collection experienced
improvements in back pain, waist mobility and overall recovery despite a
relatively short usage period. The study highlighted the home-care devices’
ability to adapt to different spinal shapes and deliver customized stimulation.
The
study comes as Ceragem, which currently exports its products to 70 countries,
seeks recognition from American medical researchers while working to meet
licensing requirements for home-care medical devices in the United States. By
demonstrating its technological capabilities through clinical research and
overcoming regulatory hurdles in the U.S., the Korean company believes it has
gained a head start in the global market.
“This
joint study has shown that Ceragem, with its 28 years of experience, now meets
global clinical research standards. We will continue to pursue joint research
with leading medical institutions worldwide to verify our technologies through
clinical studies,” a Ceragem official said.
Established
in 1998, Ceragem began its business with the Master series. Last year, the
company introduced its Master V4 device in NMR in Biomedicine, another
international medical journal, detailing its therapeutic effects.
